All Articles
Filters
Artificial Intelligence
The New Mega AI Data Centre From CoreWeave and Core Scientific
Core Scientific (NASDAQ: CORZ) and CoreWeave have officially begun construction of their new data centre located in Port Muskogee, Oklahoma.
November 19, 2024
Artificial Intelligence
Public Companies
Energy
Are Robots Going To Change The Future Of Solar Energy?
Solar energy company Array Technologies (NASDAQ: ARRY) has made a $3M USD strategic investment into Swap Robotics.
November 19, 2024
Clean Tech
Energy
Public Companies
Robotics
Crypto
The New Cryptocurrency Quietly Being Mined By Marathon Digital
Marathon Digital (NASDAQ: MARA) has been mining cryptocurrency Kaspa, which has slowly begun to build into a meaningful digital asset holding.
November 19, 2024
Bitcoin
Public Companies
Artificial Intelligence
The CHIPS Act Is Injecting Billions Into Domestic Semiconductor Production
Taiwan Semiconductor Manufacturing Company (NYSE: TSM) has landed $6.6B USD in new funding from the United States government through the CHIPS Act.
November 18, 2024
Regulatory
Artificial Intelligence
General
Artificial Intelligence
The UFC and IBM Have Shared Ambitions For Artificial Intelligence
IBM (NYSE: IBM) and the UFC have entered into a new partnership focused on leveraging IBM’s artificial intelligence models for the UFC’s live events and PPV.
November 18, 2024
Artificial Intelligence
General
Climate Tech
Bloom Energy Is Bringing Fuel Cells To Data Centres
Bloom Energy (NYSE: BE) has a new deal with American Electric Power (NASDAQ: AEP) to leverage their fuel cell technology to provide electricity to data centres.
November 18, 2024
Artificial Intelligence
Clean Tech
Bitcoin Mining
Legendary Hedge Funds Are Now Buying Bitcoin Miners
Legendary hedge fund Lone Pine Capital has begun buying publicly listed Bitcoin mining companies according to new filings with the United States SEC.
November 17, 2024
Bitcoin
Public Companies
Psychedelics
Cybin Is Launching Phase III Clinical Trials For Psychedelics
Cybin (NYSE: CYBN) is launching their Phase III clinical trial for their novel psychedelic therapeutic CYB003 for the treatment of major depressive disorder.
November 16, 2024
Biotech
Regulatory
Discover the world's most disruptive early stage companies with 40,000+ investors.
The markets and trends that matter, made simple.
Join top talent at the world's most respected institutions, companies, and venture capital funds.